NewslettersPulmonary Cell NewsKukoamine a Inhibits C-C Motif Chemokine Receptor 5 To Attenuate Lipopolysaccharide-Induced Lung InjuryBy Danielle Corrigan - July 28, 20220116Scientists elucidated the mechanism underlying the effects of Kukoamine A treatment on endotoxin-induced lung injury/inflammation.[Drug Development Research]Abstract